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EMH where SCF+/CXCL12+ cells were sought for immunohisto-
chemically.
A 64-year-old woman with postpolycythemia vera myelofi-
brosis was referred to our department for multiple red papules
on her torso. She had undergone radiation therapy for spleno-
megaly 6 months prior. Multiple non-blanchable erythematous,
smooth-surfaced papules, 2–3 mm in size, were scattered on
the torso and the proximal extremities (Fig. 1a). The complete
blood count showed pancytopenia with white blood cells 900/
lL (normal range: 2700–8500), red blood cells 2.61 9 106/lL
(3.37–4.94), Hb 7.4 g/dL (10.5–14.9), platelets 25 9 103/lL
(110–347) and reticulocytes 30.8& (7.0–20.0). The skin biopsy
from the right arm lesion indicated perivascular oedematous
changes and epidermal vacuolar changes. Haematoxylin–eosin
(HE) staining revealed perivascular infiltration of lobulated
granulocytes, orthochromatic erythroblasts and large blast-like
cells (Fig. 1b,c). These infiltrating cellular nests were immuno-
histochemically positive for the myelomonocytic lineage marker
CD33, the erythrocyte marker CD235a and the platelet marker
CD61 (Fig. 1d–f). Ectopic cellular nest formation with three
haematopoietic lineages led to the diagnosis of cutaneous
EMH. Further immunofluorescent analysis of the perivascular
stromal cells revealed the co-expression of SCF and CXCL12
(Fig. 1g,h).
Extramedullary haematopoiesis after birth is mostly
observed in the liver and spleen, and cutaneous EMH is
rarely encountered in the clinical practice.1 Accordingly, only
30 cases of cutaneous EMH were reported.6 As most studies
on EMH have been conducted on mouse models, little is
known about the pathophysiology of cutaneous EMH in
humans.3,5,7 It has been shown in mouse models that SCF+/
CXCL12+ MSC-derived cells in the niche recruit and tether
HSCs, which express corresponding receptors for these cytoki-
nes CD117 (c-KIT) and CXCR4, respectively.3,7,8 In line with
this concept, we herein identified SCF+/CXCL12+ cells in
cutaneous EMH (Fig. 1g,h). Our observation suggests that the
formation of the HSC niche may employ a similar mecha-
nism in human cutaneous EMH.
As indicated by comparison between the bone marrow and
the spleen in murine studies, different types of SCF+/CXCL12+
cells may contribute to the formation of haematologic niche.4
Further investigations are required to clarify the cellular profile
of SCF+/CXCL12+ cells in cutaneous EMH.
Consequently, we presented a case of cutaneous EMH that har-
boured SCF+/CXCL12+ cells. The findings suggest that SCF+/
CXCL12+ cells play a role in the formation of the haematopoietic
niche in cutaneous EMH.
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Blurry halos after tattooing
(tattoo blowouts): a review
of 16 cases
Editor
‘Tattoo blowout’ (TBO) refers to the diffusion of tattoo inks
deep in the hypodermis.1 Tattoo blowout presents as an asymp-
tomatic, permanent, blurry halo of colour around the tattoo. It
is rapidly visible after tattooing, but mistaken initially as a hae-
matoma. It is only weeks after when the tattoo is healed that the
customer starts to be concerned. Tattoo’s aesthetic results are
impaired, and tattooed individuals are usually dissatisfied with
the outcomes. Cases are rarely reported in the literature.1–3 We
review here a series of 15 patients with 16 TBO between 2011
and 2018, including four cases reported previously.3,4 For 93%
of the patients (14/15), TBO was the reason for consultation
(Fig. 1). Patients were seen either by direct consultation (n = 2)
or by telemedicine/e-mail consultation with dermatologists
(n = 6), with patients themselves (n = 4) or with tattooists
(n = 3). Ninety-three per cent (14/15) were young women (me-
dian age 30 years, range 19–55). All had a fair skin phototype.
Tattoos were mainly located on the upper limbs in 81.2% of the
cases (13/16), either on the inner side of the arm (69.3%, 9/13)
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or on the forearm (30.7%, 4/13). Other localizations included
the cheek, the flank and the tight (Fig. 2). Culprit colours were
black (62.75%, 10/16), blue and green in three cases each
(18.75%). Of specific interest, one man developed a bilateral
TBO on both inner arms3; a beautician attempted to tattoo
herself a mole on the cheek with a syringe and calligraphy ink,
twice within 24 h, and two patients reported painful sensations
on the tattooed area. According to patients, abstention or laser
removal treatment was recommended. Two patients chose to
have a new tattoo made over or around the TBO.
To the best of our knowledge, we report the largest series of
TBO after tattooing. The frequency of this side-effect is
unknown. In a Danish study,5 TBO was found in 1.2% of the
cases (six of 493 tattoo adverse events). However, mild cases
may go unnoticed. Tattooists may correct themselves TBO with
a new tattoo cover-up or by tattooing around to reduce its visi-
bility. Only those with visible cosmetic impairment may seek for
medical advices. The first cases were reported on the dorsum of
the foot as ‘blue-foot’ phenomenon,1,2 but TBO can happen
elsewhere, mainly on the inner side of the arms as illustrated
here. The main hypothesis is that the tattoo artist ‘tattooed to
deep’ and ink leaked out of the dermis. The ink may spread
easily within the subcutaneous fat. This hypothesis seems to be
confirmed by our findings. The thickness of the epidermis and
the dermis varies according to gender and body sites.6,7 The pre-
dominance of young women can be explained by the thickness
of the epidermis and the dermis, which is thinner compared to
men of similar age group.6,7 Thicker areas such as the back or
sun-exposed areas like the dorsal side of the arms 8 are less prone
to TBO. For instance, the thickness of the skin (epidermis and
dermis) in the inner side of the arm and the back is 1012 and
1976 lm, respectively.7 Besides, the inner side of the arm is
thicker in men (1192 lm) than in women (828 lm).7 Addi-
tional explanations include gravity (hanging down limbs), tat-
tooist’s lack of experience, excessive quantity of ink, tattoo ink
chemical properties that would allow it to spread in fatty areas.
Tattoos were mostly on flat tint-coloured designs or thick lines.
In a few cases, thinner lines could also be responsible of TBO.
For patients looking for treatment, TBO laser removal has been
reported as efficient.1,2 Tattooists should be aware of this possi-
ble side-effect in areas of thin dermis. Customers, young women
with fair skin especially, should be warned about such draw-
backs.
The author is indebted to the dermatologists (Stephane
Bosonnet, Pierrick Hans, Chantal Levy-Rameau, Samir Ousmer,
Jean-Luc Rigon, Yannis Scrivener, Lauri Tolkki), tattooists and
patients who kindly shared their cases and pictures.
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Figure 2 Anatomical distribution of 16 tattoo blowouts according
to colours and gender.
Figure 1 Various examples of tattoo blowouts with a colour blurry
halo around the tattoos.
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Genetic polymorphism of thymic
stromal lymphopoietin in Korean
patients with atopic dermatitis
and allergic march
Editor
Thymic stromal lymphopoietin (TSLP) is recognized as key
cytokine in T helper type 2 (Th 2) cell differentiation and con-
tributes to the pathogenesis of atopic disease.1 The TSLP gene
on chromosome 5q22.1 and atopic cytokine gene on 5q31 are
adjacent to each other. Based on their genetic location, it is sug-
gested that the TSLP gene is involved in the progression or activ-
ity of atopic disease. Genetic association studies involving TSLP
single nucleotide polymorphisms (SNPs) and allergic rhinitis or
asthma in different racial group have yielded disparate and
inconsistent results.2–5 Moreover, there is a lack of research con-
cerning the association between TSLP SNPs and atopic dermati-
tis (AD), especially in Asian people. AD during infancy often
preludes the development of allergic rhinitis and asthma in later
childhood, the so-called allergic march (AM). One study
revealed that epithelial cell-derived cytokine, such as TSLP,
might drive the progression from AD to asthma and food
allergy.6 Therefore, it is supposed genetic variants of TSLP affect
the progression of AD and AM. We aimed to investigate the
association between four possible TSLP polymorphisms and ato-
pic disease in a Korean population.
Four candidate TSLP SNPs observed in Asian atopic patients
were selected to carry out Sanger sequencing analysis. Interest-
ingly, rs2289276 and rs2289278 attained statistical significance
in the dominant model between the control group and AM
group (P = 0.05 and P = 0.0441, respectively; Table 1). Subjects
with the TT or CT genotypes of rs2289276 had a decreased risk
of AM (OR 0.5571). Moreover, subjects with the GG or CG
genotypes of rs2289278 had a lower risk for AM (OR 0.4848). In
the control group and all patients with AD or AM (Table 1),
compared with subjects with the AG or AA genotype of
rs3806932, those with the GG genotype were negatively associ-
ated with allergic disease risk. To find a higher probability of
developing AM than AD, we analysed the case group as AM
patients with the control group being AD patients. The GG or
CG genotypes combined with rs2289278 had a lower risk of
developing AM (Table 1). The genotype in patients did not dis-
play a meaningful correlation with total IgE level and eosinophil
count. In the control group and AD group, three SNPs
(rs3806932, rs3806933 and rs2289276) were in strong LD
(D0 > 0.90). In all cross-group comparisons, one haplotype
block was found in these SNPs (D0 > 0.90, r2 > 0.6; Fig. 1, block
1). In case–control association analysis, GTT haplotype fre-
quency of the normal control was significantly higher than the
AM group (P = 0.0308). Also, GTT haplotype frequency of the
normal control was significantly different from the AM group
(P = 0.026).
Four SNPs used in this Sanger validation have been reported
in several Asian studies.3,4,7–9 Of these, two SNPs (rs3806933
and rs2289276) located in the promoter region of TSLP gene
were assessed in functional studies.3,10 In this study, three SNPs
including rs3806933 and rs2289276 were in strong LD value and
comprised a single LD block. This association is likely to change
promoter activity and enhance AP-1 binding to the regulatory
element of TSLP.3 Regarding the regulation of the functional
expression of TSLP cytokine, an SNP to SNP interaction might
be a stronger factor than individual SNPs.
Our analysis of TSLP SNPs of Korean AD and AM patients is
the first trial. It was verified that three SNPs (rs3806932,
rs2289276 and rs2289278) are associated with susceptibility of
atopic disease. We found three SNPs (rs3806932, rs3806933 and
rs2289276) form one LD block; most especially, it is expected
that the GTT haplotype strongly contributes to AM. It is impor-
tant to see significant potential as a genetic factor in the progres-
sion of the AM.
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